Results 251 to 260 of about 788,607 (367)

A Novel Factor Xa-Inhibiting Peptide from Centipedes Venom [PDF]

, 2013
Yi Kong, Shaoqing Yu, Hao Chen, Xin Ming, Jin-Bin Wang, Zhi-Yu Li, Ji‐Fu Wei   +6 more
openalex   +1 more source

Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors

Journal of Medical Economics, 2017
S. Deitelzweig, W. Neuman, M. Lingohr-Smith, B. Menges, Jay Lin   +4 more
semanticscholar   +1 more source

In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra. [PDF]

Res Pract Thromb Haemost, 2022
Brinkman HJM, Zuurveld M, Meijers JCM.
europepmc   +1 more source

The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases. [PDF]

Sci Rep
Hamada S, Muramoto K, Akaike K, Okabayashi H, Masunaga A, Tomita Y, Ichiyasu H, Sakagami T.   +7 more
europepmc   +1 more source

Peripheral Neuropathy During Concomitant Administration of Proteasome Inhibitors and Factor Xa Inhibitors: Identifying the Likelihood of Drug-Drug Interactions. [PDF]

Front Pharmacol, 2022
Meng L, Huang J, Qiu F, Shan X, Chen L, Sun S, Wang Y, Yang J.   +7 more
europepmc   +1 more source

Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging study

, 2008
Harry R. Büller, David Deitchman, Martin H. Prins, Annelise Segers   +3 more
openalex   +1 more source

The impact of a three-factor prothrombin complex concentrate on the anticoagulatory effects of the factor Xa inhibitor edoxaban [PDF]

, 2015
Karen Brown, Prachi Wickremasingha, Dolly A. Parasrampuria, Daniel Weiss, Jarema Kochan, Victor Dishy, Ling He, Minggao Shi   +7 more
openalex   +1 more source

Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial. [PDF]

Res Pract Thromb Haemost
Hamulyák EN, Wiegers HMG, Hutten BA, de Lange ME, Timmermans A, Westerweel PE, Nijziel MR, Klok FA, Hovens MM, Kamphuisen PW, Büller HR, Middeldorp S, Scheres LJJ.   +12 more
europepmc   +1 more source

Factor Xa inhibitors vs. warfarin in patients with Hughes syndrome: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Mohtashim A, Azhar A, Mazhar S, Devi D, Danial M, Patel D, Khan O, Andani A, Khan MM, Samad S, Qureshi A, Ali H, Ejaz U, Jawad S.   +13 more
europepmc   +1 more source

Screening of Potential Thrombin and Factor Xa Inhibitors from the Danshen-Chuanxiong Herbal Pair through a Spectrum-Effect Relationship Analysis. [PDF]

Molecules, 2021
Wang X, Zhang DY, Yin SJ, Jiang H, Lu M, Yang FQ, Hu YJ.   +6 more
europepmc   +1 more source